Dra Maria J Capmartin
Bacteriologist at Universidad Pontificia Javeriana. MSc in Biology and clinic cancer, MSc in Molecular Oncology, Specialist in Clinical Genetics, MBA at UM.
Submanager
With a solid academic background and professional experience in molecular biology, oncology and clinical genetics, she serves as Submanager at Martinez clinical laboratory, leading projects focused on advancing the research and diagnosis of complex diseases.
Meet our
S C I E N T I F I C A D V I S O R Y B O A R D
Pedro Larrea, MD. Phd.
PhD in Medical Management and a Master’s in Gastroenterology from San Martín de Porres University, where he also earned his Gastroenterology Specialist Title. He completed a Fellowship in Diagnostic & Therapeutic Endoscopy at Karolinska Hospital (Sweden), specializing in EUS for GI tumor staging and FNA biopsies of the mediastinum, pancreas, and lymph nodes
His research focuses on submucosal endoscopic dissection for early GI cancer, advanced ERCP, GERD interventions, and GI bleeding management. With expertise in stent placement and intragastric balloon procedures, he integrates clinical practice and research to advance precision medicine in endoscopy.
Diana Torres, Phd.
Diana Torres is a molecular geneticist with a Ph.D. and a postdoctoral degree from the "German Cancer Research Center – DKFZ" in Heidelberg, Germany. She currently works as a full professor at the Pontificia Universidad Javeriana in Bogotá and as the Business Manager for Latin America at CeGaT, a renowned German laboratory specializing in genetic diagnostics.
CarlosBlaschke, M.D.
Carlos Blaschke, MD Director of Clinical Research at the University of Miami, Diabetes Research Institute.
Dr. Blaschke academic and professional journey has been devoted to understanding and combating type 1 diabetes. Trained in medicine and clinical research, Dr Blaschke has the privilege of directing clinical research and leading studies. He also has coordinated to the development of complex trials including the landmark teplizumab T1D prevention study, which ultimately led to FDA approval.
